On September 8, the Canadian Centre for Ethics in Sport (CCES) announced the first case involving an adverse analytical finding for human growth hormone (hGH) in North America.
This case follows the first worldwide case involving this substance announced by UK Anti-Doping in February 2010.
Click here for the CCES press release.
Click here for WADA’s February statement on the first worldwide hGH case.
Click here for a Q&A on hGH.